1037758-74-9

Basic information

• Product Name: 6-(2,5-difluorobenzyl)-N-(methylsulfonyl)-8-(2-oxo-1,2-dihydropyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide
• Synonyms: 6-(2,5-difluorobenzyl)-N-(methylsulfonyl)-8-(2-oxo-1,2-dihydropyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide
• CAS NO: 1037758-74-9
• Molecular Weight: 499.495
• Mol File: 1037758-74-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-(2,5-difluorobenzyl)-N-(methylsulfonyl)-8-(2-oxo-1,2-dihydropyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(2,5-difluorobenzyl)-N-(methylsulfonyl)-8-(2-oxo-1,2-dihydropyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide(1037758-74-9)
• EPA Substance Registry System: 6-(2,5-difluorobenzyl)-N-(methylsulfonyl)-8-(2-oxo-1,2-dihydropyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide(1037758-74-9)

Safety Data

• Hazardous Substances Data: 1037758-74-9(Hazardous Substances Data)

Upstream product

• 196799-45-8 2,3-dihydrobenzofuran-7-carbaldehyde 
• 35700-40-4 2,3-dihydrobenzofuran-7-carboxylic acid 
• 1037763-79-3 6-(2,5-difluorobenzyl)-8-(2-methoxypyridin-3-yl)-N-(methylsulfonyl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxamide 
• 1037763-65-7 N-methoxy-N-methyl-2,3-dihydrobenzofuran-7-carboxamide 
• 1037763-77-1 6-(2,5-difluorobenzyl)-8-(2-methoxypyridin-3-yl)-3,6-dihydro-2H-1-oxa-6-azaasindacene-7-carboxylic acid 
• 1037763-75-9 methyl 6-(2,5-difluorobenzyl)-8-(2-methoxypyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxylate 
• 1037763-72-6 methyl 8-(2-methoxypyridin-3-yl)-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxylate 
• 1037763-70-4 methyl 8-iodo-3,6-dihydro-2H-furo[2,3-e]indole-7-carboxylate 
• 327183-73-3 methyl 3,6-dihydro-2H-furo[2,3-e]indole-7-carboxylate 

Relevant articles and documents

Synthesis of new 4,5-dihydrofuranoindoles and their evaluation as HCV NS5B polymerase inhibitors

The synthesis of substituted 3,4-dihydrofuranoindoles is reported. These new indole compounds were used to synthesize potent HCV NS5B inhibitors. The binding mode of the dihydrofuranoindole-derived inhibitors was established via X-ray crystallographic stu